Christopher Gibson - Aug 15, 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Kyle Nelson, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Aug 15, 2025
Transactions value $
-$227,800
Form type
4
Date filed
8/19/2025, 06:22 PM
Previous filing
Aug 13, 2025
Next filing
Aug 28, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gibson Christopher Chief Executive Officer, Director C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY /s/ Kyle Nelson, attorney-in-fact 2025-08-19 0001856369

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Tax liability -$228K -40.4K -4.06% $5.64 954K Aug 15, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.